Ralf Kuriyel
Net Worth

Last updated:

What is Ralf Kuriyel net worth?

The estimated net worth of Mr. Ralf Kuriyel is at least $12,814,726 as of 2 Aug 2024. He owns shares worth $1,517,568 as insider, has earned $6,780,408 from insider trading and has received compensation worth at least $4,516,750 in Repligen Corporation.

What is the salary of Ralf Kuriyel?

Mr. Ralf Kuriyel salary is $645,250 per year as Senior Vice President of R&D in Repligen Corporation.

How old is Ralf Kuriyel?

Mr. Ralf Kuriyel is 66 years old, born in 1959.

What stocks does Ralf Kuriyel currently own?

As insider, Mr. Ralf Kuriyel owns shares in one company:

Company Title Shares Price per share Total value
Repligen Corporation (RGEN) Senior Vice President of R&D 12,288 $123.5 $1,517,568

What does Repligen Corporation do?

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

RGEN logo
RGEN
Repligen Corporation
$123.5

Ralf Kuriyel insider trading

Repligen Corporation

Mr. Ralf Kuriyel has made 22 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 7,148 units of RGEN stock worth $1,137,283 on 2 Aug 2024.

The largest trade he's ever made was exercising 8,000 units of RGEN stock on 13 May 2020. As of 2 Aug 2024 he still owns at least 12,288 units of RGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,148 $159.11 $1,137,283
Option
Stock Option (Right to Buy) 175 $86.1 $15,067
Option
Common Stock 175 $86.1 $15,067
Sale
Common Stock 4,465 $165.67 $739,717
Option
Stock Option (Right to Buy) 1,271 $86.1 $109,433
Sale
Common Stock 3,517 $193.73 $681,348
Option
Common Stock 1,271 $86.1 $109,433
Sale
Common Stock 4,040 $254.14 $1,026,726
Sale
Common Stock 800 $255.2 $204,160
Option
Stock Option (Right to Buy) 646 $86.1 $55,621
Option
Stock Option (Right to Buy) 1,354 $59.52 $80,590
Option
Common Stock 2,000 $33.05 $66,100
Option
Common Stock 1,354 $59.52 $80,590
Option
Common Stock 646 $86.1 $55,621
Sale
Common Stock 4,001 $282.13 $1,128,802
Option
Common Stock 3,602 N/A N/A
Option
Stock Option (Right to Buy) 3,602 N/A N/A
Sale
Common Stock 6,802 N/A N/A
Sale
Common Stock 710 $172.29 $122,326
Option
Common Stock 8,000 $42.15 $337,176
Sale
Common Stock 8,000 $127.4 $1,019,224
Option
Stock Option (Right to Buy) 8,000 $30.86 $246,856
Sale
Common Stock 2,075 $192.81 $400,072
Sale
Common Stock 2,075 $115.55 $239,762
Sale
Common Stock 2,075 N/A N/A
Sale
Common Stock 435 $186.18 $80,988
Sale
Common Stock 5,000 N/A N/A
Option
Stock Option (Right to Buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 435 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Option
Common Stock 8,000 $33.46 $267,680
Option
Common Stock 8,000 N/A N/A
Option
Stock Option (Right to Buy) 8,000 $33.46 $267,680
Option
Stock Option (Right to Buy) 8,000 N/A N/A
Sale
Common Stock 2,555 N/A N/A
Sale
Common Stock 450 N/A N/A
Sale
Common Stock 195 N/A N/A
Sale
Common Stock 2,240 N/A N/A
Sale
Common Stock 185 N/A N/A
Sale
Common Stock 311 N/A N/A

Repligen key executives

Repligen Corporation executives and other stock owners filed with the SEC: